Average Co-Inventor Count = 6.90
ph-index = 18
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (69 from 1,148 patents)
2. Merck Patent Gmbh (3 from 2,931 patents)
3. Other (1 from 832,575 patents)
70 patents:
1. 12258333 - N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
2. 12247021 - Substituted tetrahydrofurans as modulators of sodium channels
3. 12187731 - Compounds useful as inhibitors of ATR kinase
4. 12084438 - GCN2 inhibitors and uses thereof
5. 11919887 - Substituted tetrahydrofurans as modulators of sodium channels
6. 11834441 - Substituted tetrahydrofurans as modulators of sodium channels
7. 11827627 - N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
8. 11370798 - Compounds useful as inhibitors of ATR kinase
9. 11117900 - Compounds useful as inhibitors of ATR kinase
10. 10988477 - GCN2 inhibitors and uses thereof
11. 10961232 - Substituted pyrazines as ATR kinase inhibitors
12. 10822331 - Processes for preparing ATR inhibitors
13. 10793563 - GCN2 inhibitors and uses thereof
14. 10787452 - Compounds useful as inhibitors of ATR kinase
15. 10479784 - Substituted pyrazin-2-amines as inhibitors of ATR kinase